PFM Health Sciences’s StoneCo STNE Stock Holding History

PFM Health Sciences’s Portfolio STNE Stock Details STNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-86,453	Closed	-$1.59M	–	115
2018 Q4	$1.59M	Buy	+86,453	New	+$2M	0.04%	87

Other funds holding STNE

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Steadfast Capital Management New York $2.92B AUM 26.34% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

PFM Health Sciences's STNE Position: Q1 2019 in Review

PFM Health Sciences sold out of StoneCo (STNE) in Q1 2019, closing a stake of 86,453 shares — an estimated $1.59M sold.

PFM Health Sciences first reported a position in STNE in Q4 2018 and held it in 1 quarter. The position peaked at $1.59M in Q4 2018. 111 funds tracked by Wall St. Rank hold STNE as of Q1 2019.

PFM Health Sciences reported no remaining StoneCo position as of Q1 2019 after selling out during the quarter.
PFM Health Sciences sold 86,453 StoneCo shares in Q1 2019, an estimated $1.59M.
PFM Health Sciences first reported a position in StoneCo in Q4 2018 and held it in 1 quarter.
PFM Health Sciences's StoneCo position peaked at $1.59M in Q4 2018.
111 funds tracked by Wall St. Rank held StoneCo as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.